New insights into microRNA-29 regulation: A new key player in cardiovascular disease

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 3, 2012, Pages 584-586

  Suárez, Yajaira ^a   Fernández Hernando, Carlos ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; DNA METHYLTRANSFERASE 3B; ELASTIN; GELATINASE A; GELATINASE B; HISTONE DEACETYLASE; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN C FOS; PROTEIN MICRORNA 29; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; DNA METHYLATION; EDITORIAL; GENE EXPRESSION REGULATION; HISTONE METHYLATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION;

ANIMALS; CARDIOVASCULAR DISEASES; EPIGENESIS, GENETIC; HUMANS; LIPOPROTEINS, LDL; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84857639209     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.01.009     Document Type: Editorial

References (26)

1. Ambros V. The functions of animal microRNAs. Nature Sep 16, 2004, 431(7006):350-355.
2. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell Jan 23, 2009, 136(2):215-233.
3. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell Dec 3, 1993, 75(5):843-854.
4. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell Dec 3, 1993, 75(5):855-862.
5. Chen J.F., Murchison E.P., Tang R., Callis T.E., Tatsuguchi M., Deng Z., et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A Feb 12, 2008, 105(6):2111-2116.
6. Suarez Y., Fernandez-Hernando C., Yu J., Gerber S.A., Harrison K.D., Pober J.S., et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A Sep 16, 2008, 105(37):14082-14087.
7. Albinsson S., Suarez Y., Skoura A., Offermanns S., Miano J.M., Sessa W.C. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler Thromb Vasc Biol. Jun 2010, 30(6):1118-1126.
8. Albinsson S., Skoura A., Yu J., DiLorenzo A., Fernandez-Hernando C., Offermanns S., et al. Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function. PLoS One. Apr 22, 2011, 6(4):e18869.
9. Boettger T., Beetz N., Kostin S., Schneider J., Kruger M., Hein L., et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the miR143/145 gene cluster. J Clin Invest Sep 2009, 119(9):2634-2647.
10. Boon R.A., Seeger T., Heydt S., Fischer A., Hergenreider E., Horrevoets A.J., et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res. Oct 28, 2011, 109(10):1115-1119.
11. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature Aug 6, 2009, 460(7256):705-710.
12. Davis B.N., Hilyard A.C., Nguyen P.H., Lagna G., Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem Feb 6, 2009, 284(6):3728-3738.
13. Elia L., Quintavalle M., Zhang J., Contu R., Cossu L., Latronico M.V., et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ Dec 2009, 16(12):1590-1598.
14. Xin M., Small E.M., Sutherland L.B., Qi X., McAnally J., Plato C.F., et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev Sep 15, 2009, 23(18):2166-2178.
15. Chen J., Yin H., Jiang Y., Radhakrishnan S.K., Huang Z.P., Li J., et al. Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler Thromb Vasc Biol. Feb, 2011, 31(2):368-375.
16. Kang H, Davis-Dusenbery BN, Nguyen PH, Lal A, Lieberman J, Van Aelst L, et al. Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating miR-21, which downregulates expression of the family of Dedicator of Cytokinesis (DOCK) proteins. J Biol Chem. Dec 9, 2011 [Epub ahead of print].
17. Caruso P., MacLean M.R., Khanin R., McClure J., Soon E., Southgate M., et al. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol. Apr, 2011, 30(4):716-723.
18. van Rooij E., Sutherland L.B., Thatcher J.E., DiMaio J.M., Naseem R.H., Marshall W.S., et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A Sep 2, 2008, 105(35):13027-13032.
19. Zhang P, Huang A, Ferruzzi J, Mecham RP, Starcher BC, Tellides G, et al. Inhibition of MicroRNA-29 Enhances Elastin Levels in Cells Haploinsufficient for Elastin and in Bioengineered Vessels. Arterioscler Thromb Vasc Biol. Nov 17, 2011 [Epub ahead of print].
20. Merk D.R., Chin J.T., Dake B.A., Maegdefessel L., Miller M.O., Kimura N., et al. miR-29b Participates in Early Aneurysm Development in Marfan Syndrome. Circ Res. Jan 20, 2012, 110(2):312-324.
21. Chen K.C., Wang Y.S., Hu C.Y., Chang W.C., Liao Y.C., Dai C.Y., et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J. May, 2011, 25(5):1718-1728.
22. Mott J.L., Kurita S., Cazanave S.C., Bronk S.F., Werneburg N.W., Fernandez-Zapico M.E. Transcriptional suppression of miR-29b-1/miR-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem. Aug 1, 2010, 110(5):1155-1164.
23. Wade P.A., Pruss D., Wolffe A.P. Histone acetylation: chromatin in action. Trends Biochem Sci Apr 1997, 22(4):128-132.
24. Sampath D, Liu C, Vasan K, Sulda M, Puduvalli VK, Wierda WG, et al. Histone deacetylases mediate the silencing of miR-15a, miR-16 and miR-29b in chronic lymphocytic leukemia. Blood. Nov 16, 2011 [Epub ahead of print].
25. Espada J., Esteller M. Epigenetic control of nuclear architecture. Cell Mol Life Sci Feb 2007, 64(4):449-457.
26. Ugalde AP, Ramsay AJ, de la Rosa J, Varela I, Marino G, Cadinanos J, et al. Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53. EMBO J. Jun 1, 2011; 30(11): 2219-32.